Business NewsMarketWire • Imaging3 Set to Implement FDA Resubmission Strategy

Imaging3 Set to Implement FDA Resubmission Strategy

Imaging3 Set to Implement FDA Resubmission Strategy

BURBANK, CA--(Marketwire - November 29, 2010) - Imaging3T, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today provided insight into the Company's strategy for resubmission to the FDA.

View More : http://www.marketwire.com/mw/release.do?id=1360057&sourceType=3
Releted News by marketwire
Reservoir Capital Corp. Announces Successful Completion of $3,060,000 Private Placement
Imaging3 Set to Implement FDA Resubmission Strategy
US Farms, Inc. Announces Joint Operating Agreement With Phytoceutical Inc.